Saniona

Pharmaceutical ManufacturingHovedstaden, Denmark11-50 Employees

Saniona is a clinical-stage biopharmaceutical company focused on ion channel modulation to address epilepsy and other neurological disorders. Its epilepsy portfolio encompasses several candidates at different development stages, targeting absence seizures, acute repetitive seizures, and refractory focal onset seizures. The company operates from Glostrup, near Copenhagen, and is listed on the Nasdaq Stockholm Main Market. In addition to its epilepsy program, Saniona pursues additional clinical initiatives with potential for collaboration, supported by partnerships with organizations such as Boehringer Ingelheim and Medix. A recent development involves a collaboration with Medix to advance Tesofensine toward regulatory approval for obesity in Mexico.

Sign up for free to view info

Email Format Employee directory